Vitamin K and sphingolipid metabolism: Evidence to date

Nutrition Reviews

Volumn 63, Issue 4, 2005, Pages 111-121

  Denisova, Natalia A ^a   Booth, Sarah L ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Lipid signaling; Sphingolipids; Vitamin K

Indexed keywords

ANTICOAGULANT AGENT; CEREBROSIDE; GANGLIOSIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; MENADIONE; MENAQUINONE; PROTEIN TYROSINE KINASE; PYRIDOXAL 5 PHOSPHATE; SPHINGOLIPID; SPHINGOMYELIN; VITAMIN K GROUP; WARFARIN;

AGING; ALZHEIMER DISEASE; BRAIN REGION; CELL GROWTH; DIET; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID ANALYSIS; LIPID MEMBRANE; LIPID METABOLISM; LIPID TRANSPORT; MEMBRANE STRUCTURE; MOLECULAR MECHANICS; MYELINATION; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PLACENTAL TRANSFER; REVIEW; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANIMALS; BRAIN; HUMANS; SPHINGOLIPIDS; VITAMIN K;

EID: 16344387507     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2005.apr.111-121     Document Type: Review

References (107)

1. Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA. Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging. 2001;22:131-146.
2. Halliwell B. Plasma antioxidants: health benefits of eating chocolate? Nature 2003;426:787-788.
3. Salvati S, Attorri L, Avellino C, Di Biase A, Sanchez M. Diet, lipids and brain development. Dev Neurosci. 2000;22:481-487.
4. Kedar NP. Can we prevent Parkinson's and Alzheimer's disease? J Postgrad Med. 2003;49:236-245.
5. Gresl TA, Colman RJ, Roecker EB, et al. Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr. Am J Physiol Endocrinol Metab. 2001;281:E757-E765.
6. Gornati R, Berra B, Montorfano G, et al. Glycolipid analysis of different tissues and cerebrospinal fluid in type II Gaucher disease. J Inherit Metab Dis. 2002;25:47-55.
7. Proia RL. Glycosphingolipid functions: insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci. 2003;358:879-883.
8. Dobrowsky RT, Hannun YA. Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem. 1992;267:5048-5051.
9. Cuvillier O, Edsall L, Spiegel S. Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol Chem. 2000;275:15691-15700.
10. Fatatis A, Miller RJ. Sphingosine and sphingosine 1-phosphate differentially modulate platelet-derived growth factor-BB-induced Ca2+ signaling in transformed oligodendrocytes. J Biol Chem. 1996;271:295-301.
11. Fredman P. Sphingolipids and cell signalling. J Inherit Metab Dis. 1998;21:472-480.
12. Contreras FX, Villar AV, Alonso A, Kolesnick RN, Goni FM. Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J Biol Chem. 2003;278:37169-37174.
13. Merrill AH Jr, Schmelz EM, Dillehay DL, et al. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol. 1997;142:208-225.
14. Giusto NM, Roque ME, Ilincheta de Boschero MG. Effects of aging on the content, composition and synthesis of sphingomyelin in the central nervous system. Lipids. 1992;27:835-839.
15. D'Hooge R, Hartmann D, Manil J, Colin F, Gieselmann V, De Deyn PP. Neuromotor alterations and cerebellar deficits in aged arylsulfatase A-deficient transgenic mice. Neurosci Lett. 1999;273:93-96.
16. Marbois BN, Faull KF, Fluharty AL, Raval-Fernandes S, Rome LH. Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry. Biochim Biophys Acta. 2000;1484:59-70.
17. Lev M, Milford AF. The 3-ketodihydrosphingosine synthetase of Bacteroides melaninogenicus: induction by vitamin K. Arch Biochem Biophys. 1973;157:500-508.
18. Sundaram KS, Fan JH, Engelke JA, Foley AL, Suttie JW, Lev M. Vitamin K status influences brain sulfatide metabolism in young mice and rats. J Nutr. 1996;126:2746-2751.
19. Carrie I, Portoukalian J, Vicaretti R, Rochford J, Potvin S, Ferland G. Menaquinone-4 concentration is correlated with sphingolipid concentrations in rat brain. J Nutr. 2004;134:167-172.
20. Tsaioun KI. Vitamin K-dependent proteins in the developing and aging nervous system. Nutr Rev. 1999;57:231-240.
21. Sandhoff K, Kolter T. Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans R Soc Lond B Biol Sci. 2003;358:847-861.
22. Merrill AH Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem. 2002;277:25843-25846.
23. Smith WL, Merrill AH Jr. Sphingolipid metabolism and signaling minireview series. J Biol Chem. 2002;277:25841-25842.
24. Sillence DJ, Platt FM. Glycosphingolipids in endocytic membrane transport. Semin Cell Dev Biol. 2004;15:409-416.
25. Tardy C, Andrieu-Abadie N, Salvayre R, Levade T. Lysosomal storage diseases: is impaired apoptosis a pathogenic mechanism? Neurochem Res. 2004;29:871-880.
26. Denisova NA. Phospholipid composition of myelin and synaptosomal proteolipid from vertebrate brain. Int J Biochem. 1990;22:439-442.
27. Denisova NA, Gorbunov NV, Avrova NF. Fatty acid composition of phospholipids of myelin and synaptosomal proteolipid complexes from vertebrate brain. Int J Biochem. 1991;23:811-818.
28. Ambudkar IS, Brazer SC, Liu X, Lockwich T, Singh B. Plasma membrane localization of TRPC channels: role of caveolar lipid rafts. Novartis Found Symp. 2004;258:63-70.
29. Marx J. Caveolae: a once-elusive structure gets some respect. Science. 2001;294:1862-1865.
30. Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic. 2003;4:724-738.
31. Carver LA, Schnitzer JE. Caveolae: mining little caves for new cancer targets. Nat Rev Cancer. 2003;3:571-581.
32. Nichols B. Caveosomes and endocytosis of lipid rafts. J Cell Sci. 2003;116(part 23):4707-4714.
33. Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem. 1997;272:30429-30438.
34. Chini B, Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol. 2004;32:325-338.
35. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996;271:22810-22814.
36. Buccoliero R, Futerman AH. The roles of ceramide and complex sphingolipids in neuronal cell function. Pharmacol Res. 2003;47:409-419.
37. Barrier L, Page G, Bare S, Piriou A, Portoukalian J. Sulfatide and GM1 ganglioside modulate the high-affinity dopamine uptake in rat striatal synaptosomes: evidence for the involvement of their ionic charges. Neurochem Int. 2003;42:305-313.
38. Denisova NA, Shukitt-Hale B, Rabin BM, Joseph JA. Brain signaling and behavioral responses induced by exposure to (56)Fe-particle radiation. Radiat Res. 2002;158:725-734.
39. Denisova NA, Fisher D, Provost M, Joseph JA. The role of glutathione, membrane sphingomyelin, and its metabolites in oxidative stress-induced calcium "dysregulation" in PC12 cells. Free Radic Biol Med. 1999;27:1292-1301.
40. Denisova NA, Erat SA, Kelly JF, Roth GS. Differential effect of aging on cholesterol modulation of carbachol-stimulated low-K(m) GTPase in striatal synaptosomes. Exp Gerontol. 1998;33:249-265.
41. Tsaioun KI, Denisova NA, Obin MS, Joseph JA. Novel growth factor GAS6, phosphatidylserine and their age-related changes in the rat brain. Neurosci Res Comm. 2000;26:113-122.
42. Irizarry MC. A turn of the sulfatide in Alzheimer's disease. Ann Neurol. 2003;54:7-8.
43. Svennerholm L, Bostrom K, Jungbjer B, Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem. 1994;63:1802-1811.
44. Gottfries CG, Karlsson I, Svennerholm L. Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type. Int Psychogeriatr. 1996;8:365-372.
45. Han X, Cheng H, Fryer JD, Fagan AM, Holtzman DM. Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. J Biol Chem. 2003;278:8043-8051.
46. Sandell JH, Peters A. Disrupted myelin and axon loss in the anterior commissure of the aged rhesus monkey. J Comp Neurol. 2003;466:14-30.
47. Sandvig A, Berry M, Barrett LB, Butt A, Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia. 2004;46:225-251.
48. Norton WT. Recent advances in myelin biochemistry. Ann N Y Acad Sci. 1984;436:5-10.
49. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001;81:871-927.
50. Oshida K, Shimizu T, Takase M, Tamura Y, Yamashiro Y. Effects of dietary sphingomyelin on central nervous system myelination in developing rats. Pediatr Res. 2003;53:589-593.
51. Popko B. Myelin: not just a conduit for conduction. Nat Genet. 2003;33:327-328.
52. Svennerholm L, Bostrom K, Helander CG, Jungbjer B. Membrane lipids in the aging human brain. J Neurochem. 1991;56:2051-2059.
53. Svennerholm L, Gottfries CG. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J Neurochem. 1994;62:1039-1047.
54. Denisova N, Bielinski D, Joseph JA. The role of neutral sphingomyelinase in neuronal vulnerability and synaptic plasticity in aging. Poster presented at: Society for Neuroscience Annual Meeting; November 4-9, 2000; New Orleans, LA. Abstract available online at: http://sfn.scholarone.com/itin2000/. Accessed February 3, 2005.
55. Brann AB, Tcherpakov M, Williams IM, Futerman AH, Fainzilber M. Nerve growth factor-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J Biol Chem. 2002;277:9812-9818.
56. Obeid LM, Hannun YA. Ceramide, stress, and a "LAG" in aging. Sci Aging Knowledge Environ. 2003;2003:PE27.
57. Sawai H, Okazaki T, Takeda Y, et al. Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol. Implications in apoptosis. J Biol Chem. 1997;272:2452-2458.
58. Singh I, Pahan K, Khan M, Singh AK. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem. 1998;273:20354-20362.
59. Matsunaga T, Kotamraju S, Kalivendi SV, Dhanasekaran A, Joseph J, Kalyanaraman B. Ceramide-induced intracellular oxidant formation, iron signaling, and apoptosis in endothelial cells: protective role of endogenous nitric oxide. J Biol Chem. 2004;279:28614-28624.
60. Gallagher M. Aging and hippocampal/cortical circuits in rodents. Alzheimer Dis Assoc Disord. 2003;17(suppl 2):S45-S47.
61. Svennerholm L, Bostrom K, Jungbjer B. Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes. Acta Neuropathol (Berl). 1997;94:345-352.
62. Svennerholm L, Stallberg-Stenhagen S. Changes in the fatty acid composition of cerebrosides and sulfatides of human nervous tissue with age. J Lipid Res. 1968;9:215-225.
63. Soderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem. 1992;59:1646-1653.
64. Sonnino S, Chigorno V. Ganglioside molecular species containing C18- and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures. Biochim Biophys Acta. 2000;1469:63-77.
65. Marner L, Nyengaard JR, Tang Y, Pakkenberg B. Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol. 2003;462:144-152.
66. Peters A, Rosene DL, Moss MB, et al. Neurobiological bases of age-related cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol. 1996;55:861-874.
67. Peters A, Rosene DL. In aging, is it gray or white? J Comp Neurol. 2003;462:139-143.
68. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr. 1998;128:785-788.
69. Davidson RT, Foley AL, Engelke JA, Suttie JW. Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J Nutr. 1998;128:220-223.
70. Huber AM, Davidson KW, O'Brien-Morse ME, Sadowski JA. Tissue phylloquinone and menaquinones in rats are affected by age and gender. J Nutr. 1999;129:1039-1044.
71. Huber AM, Davidson KW, O'Brien-Morse ME, Sadowski JA. Gender differences in hepatic phylloquinone and menaquinones in the vitamin K-deficient and -supplemented rat. Biochim Biophys Acta. 1999;1426:43-52.
72. Ronden JE, Drittij-Reijnders MJ, Vermeer C, Thijssen HH. Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat. Biochim Biophys Acta. 1998;1379:69-75.
73. Ferland G. The vitamin K-dependent proteins: an update. Nutr Rev. 1998;56:223-230.
74. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood. 1999;93:1798-1808.
75. Booth SL, Martini L, Peterson JW, Saltzman E, Dallai GE, Wood RJ. Dietary phylloquinone depletion and repletion in older women. J Nutr. 2003;133:2565-2569.
76. Kameda T, Miyazawa K, Mort Y, et al. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun. 1996;220:515-519.
77. Hara K, Akiyama Y, Nakamura T, Murota S, Morita I. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone. 1995;16:179-184.
78. Koshihara Y, Hoshi K, Ishibashi H, Shiraki M. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int. 1996;59:466-473.
79. Li J, Lin JC, Wang H, et al. Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci. 2003;23:5816-5826.
80. Dowd P, Hershline R, Ham SW, Naganathan S. Vitamin K and energy transduction: a base strength amplification mechanism. Science. 1995;269:1684-1691.
81. Thijssen HH, Drittij-Reijnders MJ. Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br J Nutr. 1994;72:415-425.
82. Thijssen HH, Drittij-Reijnders MJ. Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br J Nutr. 1996;75:121-127.
83. Vermeer C, De Boer-Van den Berg MA. Vitamin K-dependent carboxylase. Haematologia (Budap). 1985;18:71-97.
84. Carlisle TL, Suttie JW. Vitamin K dependent carboxylase: subcellular location of the carboxylase and enzymes involved in vitamin K metabolism in rat liver. Biochemistry. 1980;19:1161-1167.
85. Sundaram KS, Lev M. Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain. J Lipid Res. 1988;29:1475-1479.
86. Prieto AL, Weber JL, Tracy S, Heeb MJ, Lai C. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system. Brain Res. 1999;816:646-661.
87. Stitt TN, Conn G, Gore M, et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell. 1995;80:661-670.
88. Valverde P, Obin MS, Taylor A. Role of Gas6/Axl signaling in lens epithelial cell proliferation and survival. Exp Eye Res. 2004;78:27-37.
89. Stenhoff J, Dahlback B, Hafizi S. Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. Biochem Biophys Res Commun. 2004;319:871-878.
90. Nakano T, Kawamoto K, Kishino J, Nomura K, Higashino K, Arita H. Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells. Biochem J. 1997;323(part 2):387-392.
91. Yanagita M. The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology. Curr Opin Nephrol Hypertens. 2004;13:465-470.
92. Hall MO, Obin MS, Prieto AL, Burgess BL, Abrams TA. Gas6 binding to photoreceptor outer segments requires gamma-carboxyglutamic acid (Gla) and Ca(2+) and is required for OS phagocytosis by RPE cells in vitro. Exp Eye Res. 2002;75:391-400.
93. Carrie I, Ferland G, Obin MS. Effects of long-term vitamin K (phylloquinone) intake on retina aging. Nutr Neurosci. 2003;6:351-359.
94. Lev M. Apparent requirement for vitamin K of rumen strains of Fusiformis nigrescens. Nature. 1958;181:203-204.
95. Lev M, Milford AF. Effect of vitamin K depletion and restoration on sphingolipid metabolism in Bacteroides melaninogenicus. J Lipid Res. 1972;13:364-370.
96. Lev M, Milford AF. The 3-ketodihydrosphingosine synthetase of Bacteroides melaninogenicus: partial purification and properties. Arch Biochem Biophys. 1981;212:424-431.
97. Sundaram KS, Lev M. Vitamin K and phosphate mediated enhancement of brain sulfotransferase activity. Biochem Biophys Res Commun. 1990;169:927-932.
98. Sundaram KS, Lev M. Regulation of sulfotransferase activity by vitamin K in mouse brain. Arch Biochem Biophys. 1990;277:109-113.
99. Lev M, Milford AF. Vitamin K stimulation of sphingolipid synthesis. Biochem Biophys Res Commun. 1971;45:358-362.
100. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980;68:122-140.
101. Greer F. The importance of vitamin K as a nutrient during the first year of life. Nutr Res. 1995;15:289-310.
102. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci. 2001;21:1302-1312.
103. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci. 1998;18:6241-6253.
104. Ko L, Odawara T, Yen SH. Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells. Brain Res. 1997;760:118-128.
105. Nakajima M, Furukawa S, Hayashi K, Yamada A, Kawashima T, Hayashi Y. Age-dependent survival-promoting activity of vitamin K on cultured CNS neurons. Brain Res Dev Brain Res. 1993;73:17-23.
106. Tsang CK, Kamei Y. Novel effect of vitamin K(1) (phylloquinone) and vitamin K(2) (menaquinone) on promoting nerve growth factor-mediated neurite outgrowth from PC12D cells. Neurosci Lett. 2002;323:9-12.
107. Cocchetto DM, Miller DB, Miller LL, Bjornsson TD. Behavioral perturbations in the vitamin K-deficient rat. Physiol Behav. 1985;34:727-734.